Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Behçet's syndrome: treatment with recombinant leukocyte alpha-interferon.

Literature DB >> 3740944

Behçet's syndrome: treatment with recombinant leukocyte alpha-interferon.

D Tsambaos, D Eichelberg, M Goos.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 1986 PMID： 3740944 DOI： 10.1007/bf00407749

Source DB: PubMed Journal: Arch Dermatol Res ISSN： 0340-3696 Impact factor: 3.017

× No keyword cloud information.

3 in total

Review 1. The human interferon system.

Authors: B Berman; H M Frankfort
Journal: Int J Dermatol Date: 1982 Jan-Feb Impact factor: 2.736

2. Detection of RNA complementary to herpes-simplex virus in mononuclear cells from patients with Behçet's syndrome and recurrent oral ulcers.

Authors: R P Eglin; T Lehner; J H Subak-Sharpe
Journal: Lancet Date: 1982-12-18 Impact factor: 79.321

Review 3. Behçet's disease.

Authors: R C Wong; C N Ellis; L A Diaz
Journal: Int J Dermatol Date: 1984 Jan-Feb Impact factor: 2.736

3 in total

14 in total

Review 1. Management of sight-threatening uveitis: new therapeutic options.

Authors: Matthias D Becker; Justine R Smith; Regina Max; Christoph Fiehn
Journal: Drugs Date: 2005 Impact factor: 9.546

Review 2. [Treatment of posterior noninfectious uveitis : Current situation and future developments].

Authors: U Pleyer; D Pohlmann; N Stübiger
Journal: Ophthalmologe Date: 2016-05 Impact factor: 1.059

Review 3. [Janus-faced?: Effects and side-effects of interferon therapy in ophthalmology].

Authors: N Stübiger; S Winterhalter; U Pleyer; D Doycheva; M Zierhut; C Deuter
Journal: Ophthalmologe Date: 2011-03 Impact factor: 1.059

4. [Progress in interferon: A treatment of Behcet syndrome].

Authors: D Yan; W J Zheng
Journal: Beijing Da Xue Xue Bao Yi Xue Ban Date: 2020-12-18

5. Human recombinant interferon alfa-2a for the treatment of Behçet's disease with sight threatening posterior or panuveitis.

Authors: I Kötter; M Zierhut; A K Eckstein; R Vonthein; T Ness; I Günaydin; B Grimbacher; S Blaschke; W Meyer-Riemann; H H Peter; N Stübiger
Journal: Br J Ophthalmol Date: 2003-04 Impact factor: 4.638

Behçet's syndrome: treatment with recombinant leukocyte alpha-interferon.

Review 1. The human interferon system.

2. Detection of RNA complementary to herpes-simplex virus in mononuclear cells from patients with Behçet's syndrome and recurrent oral ulcers.

Review 3. Behçet's disease.

Review 1. Management of sight-threatening uveitis: new therapeutic options.

Review 2. [Treatment of posterior noninfectious uveitis : Current situation and future developments].

Review 3. [Janus-faced?: Effects and side-effects of interferon therapy in ophthalmology].

4. [Progress in interferon: A treatment of Behcet syndrome].

5. Human recombinant interferon alfa-2a for the treatment of Behçet's disease with sight threatening posterior or panuveitis.

Review 6. Behçet Disease: An Update for Dermatologists.

Review 7. Update on the diagnosis and management of Behçet's disease.

Review 8. Updated treatment strategies for intestinal Behçet's disease.

9. Biologics in dermatologic therapy - an update.

10. Interferons and their potential in the treatment of ocular inflammation.